Literature DB >> 19821151

Cardiac matrix remodeling following intracoronary cell transplantation in dilated cardiomyopathic rabbits.

Bo Jin1, Xin-Ping Luo, Huan-Chun Ni, Yong Li, Hai-Ming Shi.   

Abstract

Cellular cardiomyoplasty has been proposed as a promising therapeutic strategy for chronic heart failure. Previous studies focused on structural changes in cardiomyocytes to explain the potential benefits for contractile function. However, limited information is available about the cardiac matrix remodeling following cell transplantation in dilated cardiomyopathy (DCM). Here, we established a new animal model of intracoronary bone marrow mononuclear cells (BMMNCs) transplantation to explore extracellular matrix remodeling in adriamycin-induced cardiomyopathic rabbits. In vivo studies demonstrated that BMMNCs transplantation can dramatically delay the progress of collagen metabolism and decrease myocardial collagen volume fraction. The beneficial effects were mediated by attenuating stress-generated over-expression of matrix metalloproteinases (MMPs) in ventricular remodeling. Improved cardiac function may be contributed in part by stem-associated inhibition of extracellular matrix remodeling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19821151     DOI: 10.1007/s11033-009-9874-y

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  20 in total

1.  Alterations in the organisation, ultrastructure and biochemistry of the myocardial collagen matrix in doberman pinschers with dilated cardiomyopathy.

Authors:  S J Gilbert; P R Wotton; A J Bailey; T J Sims; V C Duance
Journal:  Res Vet Sci       Date:  2000-12       Impact factor: 2.534

Review 2.  Implication of cardiac remodeling in heart failure: mechanisms and therapeutic strategies.

Authors:  Hiroyuki Takano; Hiroshi Hasegawa; Toshio Nagai; Issei Komuro
Journal:  Intern Med       Date:  2003-06       Impact factor: 1.271

3.  Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.

Authors:  Gerd P Meyer; Kai C Wollert; Joachim Lotz; Jan Steffens; Peter Lippolt; Stephanie Fichtner; Hartmut Hecker; Arnd Schaefer; Lubomir Arseniev; Bernd Hertenstein; Arnold Ganser; Helmut Drexler
Journal:  Circulation       Date:  2006-03-06       Impact factor: 29.690

4.  Interstitial fibrosis in the heart: differences in extracellular matrix proteins and matrix metalloproteinases in end-stage dilated, ischaemic and valvular cardiomyopathy.

Authors:  E Herpel; M Pritsch; A Koch; T J Dengler; P Schirmacher; Ph A Schnabel
Journal:  Histopathology       Date:  2006-05       Impact factor: 5.087

5.  Erythropoietin attenuates the development of experimental autoimmune myocarditis.

Authors:  Sho-Ichi Hirose; Masafumi Takahashi; Ryo Ogawa; Hajime Morimoto; Atsushi Izawa; Hajime Sato; Hirohiko Ise; Minoru Hongo; Uichi Ikeda
Journal:  Cardiovasc Drugs Ther       Date:  2007-02-13       Impact factor: 3.727

6.  Elevated serum markers of collagen degradation in patients with mild to moderate dilated cardiomyopathy.

Authors:  Bodo Schwartzkopff; Michael Fassbach; Beate Pelzer; Michael Brehm; Bodo E Strauer
Journal:  Eur J Heart Fail       Date:  2002-08       Impact factor: 15.534

7.  Selective matrix metalloproteinase inhibition with developing heart failure: effects on left ventricular function and structure.

Authors:  Mary K King; Mytsi L Coker; Aaron Goldberg; James H McElmurray; Himali R Gunasinghe; Rupak Mukherjee; Michael R Zile; Timothy P O'Neill; Francis G Spinale
Journal:  Circ Res       Date:  2003-02-07       Impact factor: 17.367

8.  Combined transmyocardial revascularization and cell-based angiogenic gene therapy increases transplanted cell survival.

Authors:  Dan Spiegelstein; Christopher Kim; Yaoguang Zhang; Guangming Li; Richard D Weisel; Ren-Ke Li; Terrence M Yau
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-09-07       Impact factor: 4.733

9.  Effects of transplanted myoblasts transfected with human growth hormone gene on improvement of ventricular function of rats.

Authors:  Shu-ling Rong; Yong-xin Lu; Yu-hua Liao; Xiao-lin Wang; Yong-jin Wang; Chao Chang; Yu-qin Wang; Qi-yun Liu; Yan-zhang Gao; Shao-hua Mi
Journal:  Chin Med J (Engl)       Date:  2008-02-20       Impact factor: 2.628

10.  Delivery route in bone marrow cell transplantation should be optimized according to the etiology of heart disease.

Authors:  Hiroyuki Nakajima; Yutaka Sakakibara; Keiichi Tambara; Akira Marui; Momoko Yoshimoto; Goditha U Premaratne; Xue Lin; Naoki Kanemitsu; Genichi Sakaguchi; Tadashi Ikeda; Kazunobu Nishimura; Tatsutoshi Nakahata; Masashi Komeda
Journal:  Circ J       Date:  2008-09       Impact factor: 2.993

View more
  5 in total

1.  Recombinant expression of human nerve growth factor beta in rabbit bone marrow mesenchymal stem cells.

Authors:  Bo-Sheng Fan; Ji-Yu Lou
Journal:  Mol Biol Rep       Date:  2010-03-17       Impact factor: 2.316

2.  Unloading the infarcted heart affect MMPs-TIMPs axis in a rat cardiac heterotopic transplantation model.

Authors:  Wei-jian Wang; Zi-li Meng; Yun-chang Mo; Jun-wei Liu; Cheng-chao Sun; Sheng-shou Hu; Hao Zhang
Journal:  Mol Biol Rep       Date:  2011-05-11       Impact factor: 2.316

3.  Animal models of cardiac disease and stem cell therapy.

Authors:  Lailiang Ou; Wenzhong Li; Yi Liu; Yue Zhang; Shen Jie; Deling Kong; Gustav Steinhoff; Nan Ma
Journal:  Open Cardiovasc Med J       Date:  2010-11-26

4.  Randomised, double-blind, placebo-controlled clinical trial for evaluating the efficacy of intracoronary injection of autologous bone marrow mononuclear cells in the improvement of the ventricular function in patients with idiopathic dilated myocardiopathy: a study protocol.

Authors:  Miguel Romero; José Suárez-de-Lezo; Concha Herrera; Manuel Pan; José López-Aguilera; José Suárez-de-Lezo; Flor Baeza-Garzón; Francisco Javier Hidalgo-Lesmes; Olga Fernández-López; Juliana Martínez-Atienza; Eva Cebrián; Vanesa Martín-Palanco; Rosario Jiménez-Moreno; Rosario Gutiérrez-Fernández; Sonia Nogueras; Maria Dolores Carmona; Soledad Ojeda; Natividad Cuende; Rosario Mata
Journal:  BMC Cardiovasc Disord       Date:  2019-08-22       Impact factor: 2.298

5.  YAP activation promotes the transdifferentiation of cardiac fibroblasts to myofibroblasts in matrix remodeling of dilated cardiomyopathy.

Authors:  Bo Jin; Jun Zhu; Hai-Ming Shi; Zhi-Chao Wen; Bang-Wei Wu
Journal:  Braz J Med Biol Res       Date:  2018-11-23       Impact factor: 2.590

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.